CancerLinQ™ Receives Major Commitment From CTCA®


Get Permission

The Conquer Cancer Foundation of ASCO has received a major commitment of support for the development of CancerLinQ™ from Cancer Treatment Centers of America, Inc (CTCA), a national network of five cancer hospitals. The donation is the largest received to date in support of CancerLinQ, a cutting-edge health information technology platform that will harness “big data” to revolutionize how we care for people with cancer.

“We are grateful for Cancer Treatment Centers of America’s support of CancerLinQ,” said ASCO President Peter Paul Yu, MD, FACP, FASCO. “CancerLinQ will allow us to learn from the experiences of every person living with cancer and, thus, transform the way it is understood and treated.”

“Since our founding 25 years ago, we have been committed to care and treatment of patients battling complex or advanced-stage diagnosis,” said CTCA President and CEO Gerard van Grinsven.
“We have also been ardent supporters of the need to bring emerging evidence-based therapies directly to the patient bedside, as quickly as possible. We believe the ASCO CancerLinQ program ranks among the most exciting developments in the evolution of cancer care and so, consistent with this commitment, we are delighted to contribute to its further development and implementation for the benefit of cancer patients everywhere.”

CancerLinQ is supported by the Conquer Cancer Foundation of ASCO. CancerLinQ is a project of ASCO’s Institute for Quality. For more information, please visit: www.asco.org/cancerlinq. ■

© 2014. American Society of Clinical Oncology. All rights reserved.

 



Advertisement

Advertisement



Advertisement